CNS Pharmaceuticals’ $4 Million Common Stock Offering

ArentFox Schiff advised CNS Pharmaceuticals, while Sullivan & Worcester advised the placement agents on the offering.CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here